Healthcare >> Analyst Interviews >> January 6, 2003
J. WILLIAM TANNER is Managing Director of Leerink Swann &
Company. He was previously with SG Cowen and Victor Securities
International. Dr. Tanner began his career in equities research
as Vice President and Biotechnology Analyst at Principal
Financial Securities in Dallas. Prior to joining Principal, he
was a Research Associate in the Department of Pathology in the
Center for Immunology at Washington University Medical School.
Dr. Tanner is the recipient of a National Research Service Award
from the National Institutes of Health and a Postdoctoral
Fellowship from the Juvenile Diabetes Foundation. He received a
BS in Animal Science from Texas A&M University, an MS in
Nutrition from Texas A&M University, a PhD in Physiology from
Texas A&M University, and an MBA from Washington University. Profile
of the biotech stocks over the past year.
Dr. Tanner: I guess the performance of the stocks is not so
surprising to me, given
